Peptide ligand recognition by G protein-coupled receptors

被引:27
|
作者
Krumm, Brian E. [1 ]
Grisshammer, Reinhard [1 ]
机构
[1] NINDS, Membrane Prot Struct Funct Unit, NIH, Rockville, MD 20852 USA
来源
FRONTIERS IN PHARMACOLOGY | 2015年 / 6卷
基金
美国国家卫生研究院;
关键词
neurotensin receptor; peptide agonist; peptide GPCRs; GPCR structure; chemokine receptors; opioid receptors; protease activated receptors; RESOLUTION CRYSTAL-STRUCTURE; OPIOID RECEPTOR; NEUROTENSIN RECEPTOR; THROMBIN RECEPTOR; COMPLEX; AGONIST; CHEMOKINE; ADRENOCEPTOR; ANTAGONISTS; CXCR4;
D O I
10.3389/fphar.2015.00048
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The past few years have seen spectacular progress in the structure determination of G protein-coupled receptors (GPCRs). We now have structural representatives from classes A, B, C, and F. Within the rhodopsin-like class A, most structures belong to the a group, whereas fewer GPCR structures are available from the beta, gamma, and groups, which include peptide GPCRs such as the receptors for neurotensin (beta group), opioids, chemokines (gamma group), and protease-activated receptors (F, group). Structural information on peptide GPCRs is restricted to complexes with non-peptidic drug-like antagonists with the exception of the chemokine receptor CXCR4 that has been crystallized in the presence of a cyclic peptide antagonist. Notably, the neurotensin receptor 1 is to date the only peptide GPCR whose structure has been solved in the presence of a peptide agonist. Although limited in number, the current peptide GPCR structures reveal great diversity in shape and electrostatic properties of the ligand binding pockets, features that play key roles in the discrimination of ligands. Here, we review these aspects of peptide GPCRs in view of possible models for peptide agonist binding.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Peptide recognition, signaling and modulation of class B G protein-coupled receptors
    Cao, Can
    Zhang, Haonan
    Yang, Zhenlin
    Wu, Beili
    CURRENT OPINION IN STRUCTURAL BIOLOGY, 2018, 51 : 53 - 60
  • [2] Modes of peptide binding in G protein-coupled receptors
    Berthold, M
    Bartfai, T
    NEUROCHEMICAL RESEARCH, 1997, 22 (08) : 1023 - 1031
  • [3] Modes of Peptide Binding in G Protein-Coupled Receptors
    Malin Berthold
    Tamas Bartfai
    Neurochemical Research, 1997, 22 : 1023 - 1031
  • [4] Peptide drugs to target G protein-coupled receptors
    Bellmann-Sickert, Kathrin
    Beck-Sickinger, Annette G.
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2010, 31 (09) : 434 - 441
  • [5] Importance of the extracellular loops in G protein-coupled receptors for ligand recognition and receptor activation
    Peeters, M. C.
    van Westen, G. J. P.
    Li, Q.
    IJzerman, A. P.
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2011, 32 (01) : 35 - 42
  • [6] Ligand-Based Peptide Design and Combinatorial Peptide Libraries to Target G Protein-Coupled Receptors
    Gruber, Christian W.
    Muttenthaler, Markus
    Freissmuth, Michael
    CURRENT PHARMACEUTICAL DESIGN, 2010, 16 (28) : 3071 - 3088
  • [7] Ligand and Decoy Sets for Docking to G Protein-Coupled Receptors
    Gatica, Edgar A.
    Cavasotto, Claudio N.
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2012, 52 (01) : 1 - 6
  • [8] Peptide-Liganded G Protein-Coupled Receptors as Neurotherapeutics
    Eiden, Lee E.
    Goosens, Ki Ann
    Jacobson, Kenneth A.
    Leggio, Lorenzo
    Zhang, Limei
    ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, 2020, 3 (02) : 190 - 202
  • [9] EGFR Transactivation by Peptide G Protein-Coupled Receptors in Cancer
    Moody, Terry W.
    Nuche-Berenguer, Bernardo
    Nakamura, Taichi
    Jensen, Robert T.
    CURRENT DRUG TARGETS, 2016, 17 (05) : 520 - 528
  • [10] Understanding Peptide Binding in Class A G Protein-Coupled Receptors
    Tikhonova, Irina G.
    Gigoux, Veronique
    Fourmy, Daniel
    MOLECULAR PHARMACOLOGY, 2019, 96 (05) : 550 - 561